Select Page

Press

  • Immunogenicity, Tregitopes and Tolerance 2011

    Immunogenicity, Tregitopes and Tolerance 2011

    Posted on December 21, 2010 by Annie De Groot
    Annie De Groot, EpiVax CEO will be speaking at the following conferences. Please click on the links for more information. We look forward to meeting you there! Invited Speaker. Regulating Immune Response in Biologics – A Paradigm- Shifting Solution. Session: Immunogenicity Issues. 2nd Annual Advancing Biologics from the Lab to the Clinic, Amsterdam, Netherlands. January 25-26, ...
    Read more
  • EpiVax CEO Named Local Hero by Bank of America

    Posted on November 21, 2010 by Annie De Groot
    EpiVax CEO Annie De Groot was one of 10 individuals honored by the Bank of America Neighborhood Excellence Initiative’s Local Heroes program for her volunteerism and civic engagement on November 2, 2010.
    Read more
  • EpiVax Receives 4th Highest Federal Grant for Healthcare Therapies in the State

    Posted on November 8, 2010 by Annie De Groot
    As part of the Therapeutic Discovery Program included in the Affordable Care Act, EpiVax has been awarded two federal grants totaling $252,722. The U.S. Department of Health and Human Services and the U.S. Treasury has awarded a total of $4.6 million in federal grants to fourteen Rhode Island biotechnology companies; EpiVax received the fourth highest ...
    Read more
  • Taking Aim at AIDS, Breast Cancer, at the 4th Annual Vaccine Renaissance Conference

    Taking Aim at AIDS, Breast Cancer, at the 4th Annual Vaccine Renaissance Conference

    Posted on October 20, 2010 by Annie De Groot
    EpiVax is truly proud to be one of the founding sponsors of the ‘Vaccine Renaissance”, an event that takes place annually in our hometown, Providence Rhode Island. Beginning on Thursday, leaders in the field will meet at the University of Rhode Island’s Feinstein campus to discuss the latest trends in vaccine research, vaccine delivery, clinical ...
    Read more
  • Anne De Groot and Her Work at EpiVax Featured in Smith Alumnae Quarterly

    Anne De Groot and Her Work at EpiVax Featured in Smith Alumnae Quarterly

    Posted on October 8, 2010 by epivax3
    Annie De Groot ’78 is using mathematical models and cutting-edge computer science to map the body’s response to disease. Her goal is to eradicate some of the world’s deadliest illnesses by making vaccines—and health care— available to everyone.  Read the full article at Smith Alumnae Quarterly- De Groot Article.
    Read more
  • EpiVax Awarded Additional NIH Funds for anti-Dec205 Project

    EpiVax Awarded Additional NIH Funds for anti-Dec205 Project

    Posted on October 6, 2010 by epivax3
    This year, EpiVax was awarded $243,561 in Total Direct and Indirect Funding to support the development of their unique HIV vaccine platform (de-tolerized anti-Dec205). The total amount awarded to date is $797,855 in Direct and Indirect costs, to further this aspect of the GAIA Vaccine development program.
    Read more
  • EpiVax Technology Lands $511K Grant to Expand Research on Vaccines for Neglected Tropical Diseases

    EpiVax Technology Lands $511K Grant to Expand Research on Vaccines for Neglected Tropical Diseases

    Posted on September 28, 2010 by epivax3
    PROVIDENCE, R.I. – September 21, 2010 – Adding to a $13 million grant awarded to her Institute for Immunology and Informatics last summer, EpiVax CEO Annie De Groot has received an additional $511,121 from the National Institutes of Health to expand the use of immunoinformatics tools to neglected tropical disease research. The funding will promote ...
    Read more
  • Upcoming Talks on EpiVax Tregitope Technology: a Paradigm Shift

    Upcoming Talks on EpiVax Tregitope Technology: a Paradigm Shift

    Posted on September 7, 2010 by epivax3
    Want to catch the news on a paradigm-shifting technology for reducing immunogenicity? Starting in Asia, EpiVax will be presenting the Tregitope paradigm shift at high quality, scientific conferences.
    Read more
  • Tregitope at American Transplant Congress: Plenary Talk May 2010

    Tregitope at American Transplant Congress: Plenary Talk May 2010

    Posted on September 7, 2010 by epivax3
    Validation of the Tregitope technology in the context of Transplants – both in vitro (MLR) assays and in vivo (skin and heart transplant) studies show that Tregitopes expand natural Tregs and induce adaptive tolerance.
    Read more
  • EpiVax Research on Tregitopes Wins 2010 AAPS Innovation in Biotechnology Award

    EpiVax Research on Tregitopes Wins 2010 AAPS Innovation in Biotechnology Award

    Posted on May 18, 2010 by epivax3
    Providence-based biotechnology company selected from more than 100 global research initiatives aimed at impacting drug development Tregitope Innovation Award Press Release (PDF) May 18, 2010 (Providence, RI; San Francisco, CA)—At the American Association of Pharmaceutical Scientists’ (AAPS) 2010 National Biotechnology Conference (NBC) in San Francisco, AAPS President Danny D. Shen, Ph.D., presented an award for “Innovation ...
    Read more
  • Clinica Esperanza in Providence Journal

    Clinica Esperanza in Providence Journal

    Posted on May 4, 2010 by epivax3
    From projo.com Free clinic finds ‘real’ home 01:00 AM EDT on Tuesday, May 4, 2010 By Philip Marcelo Journal Staff Writer Dr. Anne De Groot conducts a tour to show construction progress on the future site of the clinic on Valley Street in Olneyville. The Providence Journal /Andrew Dickerman PROVIDENCE — Clinica Esperanza/Hope Clinic, a free, largely volunteer health-care clinic that has been operating for ...
    Read more
  • "Knowledge District" in May 2010 Rhode Island Monthly

    Posted on May 1, 2010 by Annie De Groot
    Knowledge District: Five scientists whose cutting-edge research is giving the historic jewelry district a new name With the rerouting of I-195 in Providence and the dismantling of the decrepit old highway that cut off one corner of the city, the overlooked Jewelry District, once the city’s manufacturing engine, is now the site of high-tech economic development. ...
    Read more
  • “Knowledge District” in May 2010 Rhode Island Monthly

    Posted on May 1, 2010 by epivax3
    Knowledge District: Five scientists whose cutting-edge research is giving the historic jewelry district a new name With the rerouting of I-195 in Providence and the dismantling of the decrepit old highway that cut off one corner of the city, the overlooked Jewelry District, once the city’s manufacturing engine, is now the site of high-tech economic development. ...
    Read more
  • Dr. Annie De Groot on NPR: "This I Believe"

    Posted on April 22, 2010 by Annie De Groot
    This I Believe – Rhode Island – Anne De Groot “This I Believe — Rhode Island” host Frederic Reamer asks Annie to share what she believes about Health Care. (Player requires Flash and JavaScript) Listen to “This I Believe – Rhode Island” Archive on WRNI.org: Health Care “If we have learned anything as a nation in recent years, ...
    Read more
  • Dr. Annie De Groot on NPR: "This I Believe"

    Dr. Annie De Groot on NPR: “This I Believe”

    Posted on April 22, 2010 by epivax3
    This I Believe – Rhode Island – Anne De Groot “This I Believe — Rhode Island” host Frederic Reamer asks Annie to share what she believes about Health Care. (Player requires Flash and JavaScript) Listen to “This I Believe – Rhode Island” Archive on WRNI.org: Health Care “If we have learned anything as a nation in recent years, ...
    Read more

Join our newsletter

We strive to provide our clients, collaborators and everyday immunology enthusiasts with valuable content.  Written by our CEO/CSO Dr. Anne Dr Groot, you can expect up to date vaccine development efforts, upcoming events and so much more from our offices here in Providence, RI.

Click Here